Skip to main content
mSphere logoLink to mSphere
letter
. 2023 Apr 25;8(3):e00165-23. doi: 10.1128/msphere.00165-23

Statement in Support of: “Virology under the Microscope—a Call for Rational Discourse”

Peter Speck a,, Jason Mackenzie b, Rowena A Bull c, Barry Slobedman d, Heidi Drummer e, Johanna Fraser f, Lara Herrero g, Karla Helbig h, Sarah Londrigan b, Gregory Moseley f, Natalie Prow i, Grant Hansman g, Robert Edwards a, Chantelle Ahlenstiel c, Allison Abendroth d, David Tscharke j, Jody Hobson-Peters k, Robson Kriiger-Loterio f, Rhys Parry k, Glenn Marsh l, Emma Harding m, David A Jacques m, Matthew J Gartner b, Wen Shi Lee b, Julie McAuley b, Paola Vaz n, Frank Sainsbury o, Michelle D Tate f,p, Jane Sinclair k, Allison Imrie q, Stephen Rawlinson f, Andrew Harman d,r, Jillian M Carr a, Ebony A Monson h, Merilyn Hibma s, Timothy J Mahony k, Thomas Tu d,r, Robert J Center e, Lok Bahadur Shrestha c, Robyn Hall t,u, Morgyn Warner v,w, Vernon Ward x, Danielle E Anderson b, Nicholas S Eyre a, Natalie E Netzler y,z, Alison J Peel o, Peter Revill aa, Michael Beard v, Alistair R Legione n, Alexandra J Spencer bb, Adi Idris cc,g, Jade Forwood dd, Subir Sarker h, Damian F J Purcell b, Nathan Bartlett bb, Joshua M Deerain b, Bruce J Brew m,ee,ff, Sassan Asgari k, Helen Farrell k, Alexander Khromykh k, Daniel Enosi Tuipulotu j, David Anderson e, Sevim Mese gg,k, Yaman Tayyar g,hh, Kathryn Edenborough f, Jasim Muhammad Uddin ii, Abrar Hussain jj, Connor J I Daymond b, Jacinta Agius h, Karyn N Johnson k, Paniz Shirmast g, Mahdi Abedinzadeshahri oo, Robin MacDiarmid pp, Caroline L Ashley d, Jay Laws h, Lucy L Furfaro q, Thomas D Burton a, Stephen M R Johnson a, Zahra Telikani h, Mary Petrone d, Justin A Roby dd, Carolyn Samer d, Andreas Suhrbier k,kk, April Van Der Kamp a, Anthony Cunningham d,r, Celeste Donato ll, Jackie Mahar d, Wesley D Black mm, Subhash Vasudevan nn, Roman Lenchine a, Kirsten Spann cc, Daniel J Rawle kk, Penny Rudd g, Jessica Neil b, Richard Kingston y, Timothy P Newsome d, Ki Wook Kim m, Johnson Mak g, Kym Lowry k, Nathan Bryant bb, Joanne Meers k, Jason A Roberts b,aa, Nigel McMillan g, Larisa I Labzin k, Andrii Slonchak k, Leon E Hugo kk, Bennett Henzeler s, Natalee D Newton k, Cassandra T David f, Patrick C Reading qq,n, Camille Esneau bb, Tatiana Briody k, Najla Nasr r,d, Donna McNeale o, Brian McSharry dd, Omid Fakhri u, Bethany A Horsburgh c, Grant Logan rr, Paul Howley ss, Paul Young k
PMCID: PMC10286701  PMID: 37097028

LETTER

We, members of the Australasian Virology Society, agree with and support the statement entitled “Virology under the Microscope—a Call for Rational Discourse” (1). Like virologists everywhere, we have worked with scientist and clinician colleagues worldwide to develop knowledge, tests, and interventions which collectively have reduced the number of deaths due to COVID-19 and curtailed its economic impact. Such work adds to the extraordinary achievements resulting from virology research that have delivered vaccines and/or antivirals against a long list of diseases and global scourges, including AIDS, smallpox, and polio (1).

We believe the question of the origin of SARS-CoV-2 should be approached with an open mind and in consideration of the best scientific evidence available. We concur with the view that the zoonosis hypothesis has the strongest supporting evidence (24), and this is a scenario that has been observed repeatedly in the past (5), including in Australia (6). Recent data strongly support the zoonosis hypothesis (7). We share the concern that emotive and fear-based dialogues in this area add to public confusion and can lead to ill-informed condemnation of virology research.

We believe the current narrative used by some parties—that gain-of-function research is synonymous with high-risk or nefarious activity—fails to appreciate, first, the true scientific value of this legitimate approach to experimental design and, second, the strength and effectiveness of current regulations. There is an extensive history of gain-of-function research safely and effectively contributing to the development of vaccines and antivirals (1). A recent review of gain-of-function studies conducted by the Australian Government defined gain-of-function research as “a change to the genome of any biological entity—a living organism such as an animal, insect, plant, virus, bacterium, or fungus—through any process so that it acquires a new or enhanced function”. The review concluded that oversight of gain-of-function research in Australia is comprehensive and robust (8).

We do not believe virology research needs additional legislative controls. As in the United States, regulations in our region applying to virology research are strong, effective, and provide powerful oversight of manipulations of viruses by researchers. We support the call to legislators to resist fear-based campaigns that might lead to unnecessary and counter-productive restrictions being placed on virology research and may limit progress toward new antiviral drugs and vaccines.

We echo the call for policy makers, virologists, and biosafety experts to work together to ensure that research is conducted safely, with the common goal of reducing the burden of disease caused by viruses.

ACKNOWLEDGMENTS

The opinions expressed reflect those of the authors and not necessarily those of the authors’ institutions or funding agencies. No funding was used to support this commentary, but we wish to disclose funding from agencies received by authors. Flinders University: P.S.; La Trobe University: K.H.; Diabetes Australia: P.S.; Australian Government National Health and Medical Research Council: P.S., J.F., A.A., K.H., L.H., B.S., S.L., D.C.T., D.A.J., J.M., A.H., J.M.C., M.W., N.S.E., M.B., B.J.B., Y.T., L.L.F., K.W.K., L.I.L., and N.D.N.; Australian Research Council: J.F., R.E., D.C.T., D.A.J., P.V., F.S., S.S., J.M., and L.I.L.; Fisheries Research and Development Corporation: K.H. and P.S.; Victorian Medical Research Acceleration Fund: H.D.; Medical Research Future Fund: H.D., and Y.T.; mRNA Victoria: H.D.; United States NIH: R.E.; Australian National University: D.C.T.; DMTC: D.C.T.; Advance Queensland: J.H.P.; CSIRO: G.M., F.S., and D.M.; Wellcome Trust: D.A.J.; UNSW: D.A.J.; University of Melbourne: W.S.L. and P.V.; Medical Research Future Fund: J.M.; Channel 7 Children’s Research Foundation: J.M.C.; New Zealand Ministry for Business Innovation and Employment: V.W.; Health Research Council of New Zealand: N.E.N.; Innovation and Technology Commission, Hong Kong Special Administrative Region, China: M.P.; Department of Education Regional Research Collaboration Grant, Training Hub promoting Regional Industry and Innovation in Virology and Epidemiology (THRIIVE), J.A.R.; Juvenile Diabetes Research Foundation: K.W.K.; University of Queensland: K.L.

Footnotes

Ed. Note: This letter is being published by the following ASM journals: Journal of Virology, mBio, and mSphere.

REFERENCES

  • 1.Goodrum F, Lowen AC, Lakdawala S, Alwine J, Casadevall A, Imperiale MJ, Atwood W, Avgousti D, Baines J, Banfield B, Banks L, Bhaduri-McIntosh S, Bhattacharya D, Blanco-Melo D, Bloom D, Boon A, Boulant S, Brandt C, Broadbent A, Brooke C, Cameron C, Campos S, Caposio P, Chan G, Cliffe A, Coffin J, Collins K, Damania B, Daugherty M, Debbink K, DeCaprio J, Dermody T, Dikeakos J, DiMaio D, Dinglasan R, Duprex WP, Dutch R, Elde N, Emerman M, Enquist L, Fane B, Fernandez-Sesma A, Flenniken M, Frappier L, Frieman M, Frueh K, Gack M, Gaglia M, Gallagher T, Galloway D, et al. 2023. Virology under the microscope—a call for rational discourse. J Virol 97:e00089-23. doi: 10.1128/jvi.00089-23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Holmes EC, Goldstein SA, Rasmussen AL, Robertson DL, Crits-Christoph A, Wertheim JO, Anthony SJ, Barclay WS, Boni MF, Doherty PC, Farrar J, Geoghegan JL, Jiang XW, Leibowitz JL, Neil SJD, Skern T, Weiss SR, Worobey M, Andersen KG, Garry RF, Rambaut A. 2021. The origins of SARS-CoV-2: a critical review. Cell 184:4848–4856. doi: 10.1016/j.cell.2021.08.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Garry RF. 2022. The evidence remains clear: SARS-CoV-2 emerged via the wildlife trade. Proc Natl Acad Sci USA 119. doi: 10.1073/pnas.2214427119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Alwine JC, Casadevall A, Enquist LW, Goodrum FD, Imperiale MJ. 2023. A critical analysis of the evidence for the SARS-CoV-2 origin hypotheses. J Virol 0:e00365-23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Plowright RK, Parrish CR, McCallum H, Hudson PJ, Ko AI, Graham AL, Lloyd-Smith JO. 2017. Pathways to zoonotic spillover. Nat Rev Microbiol 15:502–510. doi: 10.1038/nrmicro.2017.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Mahalingam S, Herrero LJ, Playford EG, Spann K, Herring B, Rolph MS, Middleton D, McCall B, Field H, Wang LF. 2012. Hendra virus: an emerging paramyxovirus in Australia. Lancet Infect Dis 12:799–807. doi: 10.1016/S1473-3099(12)70158-5. [DOI] [PubMed] [Google Scholar]
  • 7.Crits-Christoph A, Gangavarapu K, Pekar JE, Moshiri N, Singh R, Levy JI, Goldstein SA, Suchard MA, Popescu S, Robertson DL, Lemey P, Wertheim JO, Garry RF, Rasmussen AL, Andersen KG, Holmes EC, Rambaut A, Worobey M, Débarre Florence. 2023. Genetic evidence of susceptible wildlife in SARS-CoV-2 positive samples at the Huanan Wholesale Seafood Market, Wuhan: Analysis and interpretation of data released by the Chinese Center for Disease Control. https://zenodo.org/record/7754299#.ZBsVyfZBycF.
  • 8.Australian Government. 2022. Research Review Report. Australian Government, Canberra, Australia. Accessed March 25 2023. [Google Scholar]

Articles from mSphere are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES